These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 12153601)

  • 1. Suppression of puberty with long-acting goserelin (Zoladex-LA): effect on gonadotrophin response to GnRH in the first treatment cycle.
    Trueman JA; Tillmann V; Cusick CF; Foster P; Patel L; Hall CM; Price DA; Clayton PE
    Clin Endocrinol (Oxf); 2002 Aug; 57(2):223-30. PubMed ID: 12153601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Zoladex LA (goserelin) in the treatment of girls with central precocious or early puberty.
    Paterson WF; McNeill E; Reid S; Hollman AS; Donaldson MD
    Arch Dis Child; 1998 Oct; 79(4):323-7. PubMed ID: 9875042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gonadotrophin and prolactin secretory dynamics in girls with normal puberty, idiopathic precocious puberty and precocious puberty due to hypothalamic hamartoma.
    Uriarte MM; Klein KO; Barnes KM; Pescovitz OH; Loriaux DL; Cutler GB
    Clin Endocrinol (Oxf); 1998 Sep; 49(3):363-8. PubMed ID: 9861328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Auxological outcome and time to menarche following long-acting goserelin therapy in girls with central precocious or early puberty.
    Paterson WF; McNeill E; Young D; Donaldson MD
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):626-34. PubMed ID: 15521967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of basal LH in monitoring central precocious puberty treatment in girls.
    Calcaterra V; De Filippo G; Albertini R; Rendina D; Messini B; Monti CM; Bozzola E; Villani A; Bozzola M
    J Pediatr Endocrinol Metab; 2021 Jan; 34(1):45-50. PubMed ID: 33189082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-year results of treatment with depot leuprolide acetate for central precocious puberty.
    Neely EK; Hintz RL; Parker B; Bachrach LK; Cohen P; Olney R; Wilson DM
    J Pediatr; 1992 Oct; 121(4):634-40. PubMed ID: 1403402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central precocious puberty: clinical and laboratory features.
    Chemaitilly W; Trivin C; Adan L; Gall V; Sainte-Rose C; Brauner R
    Clin Endocrinol (Oxf); 2001 Mar; 54(3):289-94. PubMed ID: 11298079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between luteinizing hormone and estradiol secretion in female precocious puberty: evaluation by sensitive gonadotropin assays and the leuprolide stimulation test.
    Garibaldi LR; Aceto T; Weber C; Pang S
    J Clin Endocrinol Metab; 1993 Apr; 76(4):851-6. PubMed ID: 8473395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathophysiology of gonadotropin secretion in patients with idiopathic precocious puberty and follow up studies during and after therapy with medroxyprogesterone acetate (author's transl)].
    Aono T; Minagawa J; Terakawa N; Kurachi K; Matsumoto K
    Nihon Naibunpi Gakkai Zasshi; 1975 Nov; 51(11):898-907. PubMed ID: 1241847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gonadotropin-releasing hormone testing in premature thelarche.
    Choubtum L; Mahachoklertwattana P; Sriphrapradang A; Preeyasombat C
    J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S33-8. PubMed ID: 10730515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simplified gonadotrophin-releasing hormone test for precocious puberty.
    Cavallo A; Richards GE; Busey S; Michaels SE
    Clin Endocrinol (Oxf); 1995 Jun; 42(6):641-6. PubMed ID: 7634506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the gonadotrophin-releasing hormone agonist 'Zoladex' upon pituitary and gonadal function in hypogonadal (hpg) male mice: a comparison with normal male and testicular feminized (tfm) mice.
    Scott IS; Bennett MK; Porter-Goff AE; Harrison CJ; Cox BS; Grocock CA; O'Shaughnessy PJ; Clayton RN; Craven R; Furr BJ
    J Mol Endocrinol; 1992 Jun; 8(3):249-58. PubMed ID: 1385960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-month sustained-release triptorelin (11.25 mg) in the treatment of central precocious puberty.
    Carel JC; Blumberg J; Seymour C; Adamsbaum C; Lahlou N;
    Eur J Endocrinol; 2006 Jan; 154(1):119-24. PubMed ID: 16382000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Girls with Premature Thelarche Younger than 3 Years of Age May Have Stimulated Luteinizing Hormone Greater than 10 IU/L.
    Seymen Karabulut G; Atar M; Çizmecioğlu Jones FM; Hatun Ş
    J Clin Res Pediatr Endocrinol; 2020 Nov; 12(4):377-382. PubMed ID: 32349465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effectiveness of depot gonadotropin-releasing hormone analogue in the treatment of children with central precocious puberty.
    Clemons RD; Kappy MS; Stuart TE; Perelman AH; Hoekstra FT
    Am J Dis Child; 1993 Jun; 147(6):653-7. PubMed ID: 8506834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single luteinizing hormone determination 2 hours after depot leuprolide is useful for therapy monitoring of gonadotropin-dependent precocious puberty in girls.
    Brito VN; Latronico AC; Arnhold IJ; Mendonca BB
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4338-42. PubMed ID: 15356030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pattern of gonadotropin and estradiol secretion in exaggerated thelarche.
    Garibaldi LR; Aceto T; Weber C
    Acta Endocrinol (Copenh); 1993 Apr; 128(4):345-50. PubMed ID: 8498153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty.
    Feuillan PP; Jones JV; Barnes K; Oerter-Klein K; Cutler GB
    J Clin Endocrinol Metab; 1999 Jan; 84(1):44-9. PubMed ID: 9920060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of a monthly compared to 3-monthly depot GnRH analogue (goserelin) in the treatment of children with central precocious puberty.
    Isaac H; Patel L; Meyer S; Hall CM; Cusick C; Price DA; Clayton PE
    Horm Res; 2007; 68(4):157-63. PubMed ID: 17356292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spontaneous serum gonadotropin concentrations in the evaluation of precocious puberty.
    Neely EK; Wilson DM; Lee PA; Stene M; Hintz RL
    J Pediatr; 1995 Jul; 127(1):47-52. PubMed ID: 7608810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.